Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-04-25
1991-09-24
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548494, C07D20918, A61K 31405
Patent
active
050514423
ABSTRACT:
The present invention is directed to a new class of 3-indolyl thioacetate derivatives which the NMDA antagonists.
REFERENCES:
Greenamyre, J. T., "Arch, Neurol.", vol. 43, pp. 1058-1063 (1986).
Olney, J. W., "Biol. Psychiatry", 26, pp. 505-525 (1989).
Robinson et al "Glutamate and Related Neurotransmitters", pp. 446-455.
Dingledine et al, TiPS, Aug. 1990 pp. 334-338.
Baron Bruce M.
Salituro Francesco G.
Dixon J. Michael
Merrell Dow Pharmaceuticals Inc.
Springer David B.
LandOfFree
3-indolyl thioacetate derivatives and NMDA receptor antagonistic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-indolyl thioacetate derivatives and NMDA receptor antagonistic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-indolyl thioacetate derivatives and NMDA receptor antagonistic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1696985